CA9 and neoplasm: Very interestingly, Zavada et al. described a soluble form of CA IX, approximately 4 kDa smaller than the full-length protein comprising the extracellular domain of CA IX that is shed (sCA IX) after protolithic cleavage from the surface of tumor cells [160] in the body fluids (blood, urine) of patients with RCCC.